studies < study < studying

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 185.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000005 (2020)	Augustin Latourte [France] ; Hang-Korng Ea [France] ; Aline Frazier [France] ; Anne Blanchard [France] ; Frédéric Lioté [France] ; Hubert Marotte [France] ; Thomas Bardin [France] ; Pascal Richette [France]	Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study.
000012 (2020)	Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France]	Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
000013 (2020)	Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis]	Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes
000021 (2020)	Giacomo Bellani [Italie] ; Tài Pham [France] ; John G. Laffey [Irlande (pays)]	Missed or delayed diagnosis of ARDS: a common and serious problem
000023 (2020)	Hermine I. Brunner [États-Unis] ; Nikolay Tzaribachev [Allemagne] ; Gabriel Vega Cornejo ; Rik Joos [Belgique] ; Elisabeth Gervais [France] ; Rolando Cimaz [Italie] ; Inmaculada Calvo Penadés [Espagne] ; Rubén Cuttica [Argentine] ; Thomas Lutz [Allemagne] ; Pierre Quartier [France] ; Yash Gandhi [États-Unis] ; Marleen Nys [Belgique] ; Robert Wong [États-Unis] ; Alberto Martini [Italie] ; Daniel J. Lovell [États-Unis] ; Nicolino Ruperto [Italie]	Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
000026 (2020)	François Santinon [France] ; Maxime Batignes [France] ; Majda Lyna Mebrek [France] ; Jerôme Biton [France] ; Gaëlle Clavel [France] ; Roxane Hervé [France] ; Delphine Lemeiter [France] ; Magali Breckler [France] ; Florence Busato [France] ; Jorg Tost [France] ; Marianne Ziol [France] ; Marie-Christophe Boissier [France] ; Patrice Decker [France] ; Luca Semerano [France] ; Natacha Bessis [France]	Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis.
000027 (2020)	Cécile Dumaine [France] ; Sara Bekkar [France] ; Alexandre Belot [France] ; Natalia Cabrera [France] ; Salma Malik [France] ; Annette Von Scheven [Suisse] ; Aurelia Carbasse [France] ; Andreas Woerner [Suisse] ; Carine Wouters [Belgique] ; Kenza Bouayed ; Pascal Pillet [France] ; Silke Schroeder [Suisse] ; Michael Hofer [Suisse] ; Véronique Hentgen [France]	Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte.
000034 (2020)	Gaëlle Vial [France] ; Anaïs De Pouilly [France] ; Laetitia Scouppe [France] ; Bruno Pereira [France] ; Claire Daien [France] ; Cédric Lukas [France] ; Adeline Ruyssen-Witrand [France] ; Pascale Vergne-Salle [France] ; Christophe Richez [France] ; Anne Tournadre [France]	Factors influencing the choice of biologic therapy following Rituximab in patients with rheumatoid arthritis: A retrospective study using propensity score.
000036 (2020)	Lutz Wollin [Allemagne] ; Dieudonnée Togbe [France] ; Bernhard Ryffel [France]	Effects of Nintedanib in an Animal Model of Liver Fibrosis
000037 (2020)	Martin Michaud [France] ; Olivier Lidove [France] ; Boris Bienvenu [France] ; Laurent Chiche [France] ; Geoffrey Urbanski [France]	Effectiveness and tolerance of off-label use of tocilizumab in autoimmune diseases: A Multicenter Study.
000047 (2020)	Julianne Duhazé [Canada, France] ; Signe H Ssler [France] ; Delphine Bachelet [France] ; Aude Gleizes [France] ; Salima Hacein-Bey-Abina [France] ; Matthieu Allez [France] ; Florian Deisenhammer [Autriche] ; Anna Fogdell-Hahn [Suède] ; Xavier Mariette [France] ; Marc Pallardy [France] ; Philippe Broët [Canada, France]	A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort
000052 (2019-06-12)	Alain Saraux [France] ; Thomas Barnetche [France] ; Guy Baudens [France] ; Isabelle Idier [France] ; Flore Delaporte [France] ; Pascal Hilliquin [France]	Subcutaneous tocilizumab in monotherapy or in combination with csdmard in patients with moderate to severe rheumatoid arthritis: observational study to describe real-world drug retention rate at 12 months.
000055 (2019)	Guillaume Rollin [France] ; José Lages [France] ; Dima L. Shepelyansky [France]	Wikipedia network analysis of cancer interactions and world influence
000057 (2019)	Christoph Lohan [Royaume-Uni] ; Alex Diamantopoulos [Royaume-Uni] ; Corinne Lereun [France] ; Emily Wright [Royaume-Uni] ; Natalie Bohm [Royaume-Uni] ; Laura Marie Sawyer [Royaume-Uni]	Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
000059 (2019)	Jean Darloy [France] ; Nicolas Segaud [France] ; Jean-Hugues Salmon [France] ; Jean-Paul Eschard [France] ; Vincent Goëb [France] ; Xavier Deprez [France] ; Marie-Hélène Guyot [France] ; Eric Houvenagel [France] ; Nicolas Lecuyer [France] ; Laurent Marguerie [France] ; Samuel Gally [France] ; David Pau [France] ; Isabelle Idier [France] ; Guy Baudens [France] ; René-Marc Flipo [France]	Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
000061 (2019)	T. Chazal [France] ; M. Costopoulos [France] ; E. Maillart [France] ; C. Fleury [France] ; D. Psimaras [France] ; P. Legendre [France] ; M. Pineton De Chambrun [France] ; J. Haroche [France] ; C. Lubetzki [France] ; Z. Amoura [France] ; M. Legarff-Tavernier [France] ; F. Cohen Aubart [France]	The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
000062 (2019)	Narjes Babchia [France] ; Solange Landreville [Canada] ; Bruno Clément [France] ; Cédric Coulouarn [France] ; Frédéric Mouriaux [France]	The bidirectional crosstalk between metastatic uveal melanoma cells and hepatic stellate cells engenders an inflammatory microenvironment.
000067 (2019)	Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse]	Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
000068 (2019)	Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France]	Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.
000072 (2019)	Olivier Vittecoq [France] ; Sandra Desouches [France] ; Marie Kozyreff [France] ; Julia Nicolau [France] ; Sophie Pouplin [France] ; Pascal Rottenberg [France] ; Nicolas Sens [France] ; Thierry Lequerre [France] ; Gilles Avenel [France]	Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study
000074 (2019)	Mike Becker [Suisse] ; Nicole Graf [Suisse] ; Rafael Sauter [Royaume-Uni] ; Yannick Allanore [France] ; John Curram [Royaume-Uni] ; Christopher P. Denton [Royaume-Uni] ; Dinesh Khanna [États-Unis] ; Marco Matucci-Cerinic [Italie] ; Janethe De Oliveira Pena [États-Unis] ; Janet E. Pope [Canada] ; Oliver Distler [Suisse]	Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i -k "study" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i  \
                -Sk "study" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    study
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021